ProMIS Neurosciences Inc. 8-K

What Happened
ProMIS Neurosciences, Inc. (PMN) announced on May 12, 2026 (Form 8‑K, Item 2.02) that it issued a press release reporting its financial condition and results for the quarter ended March 31, 2026. The press release is posted on the company website (www.promisneurosciences.com, Investors → Financial Results) and is furnished as Exhibit 99.1 to the 8‑K. The report was signed by CEO Neil Warma.

Key Details

• Filing date: May 12, 2026 (Form 8‑K, Item 2.02 and Item 9.01).
• Period reported: quarter ended March 31, 2026.
• Press release: furnished as Exhibit 99.1 and available on the company’s Investors/Financial Results web page.
• Signature: 8‑K signed by Neil Warma, Chief Executive Officer.

Why It Matters
This 8‑K notifies investors that ProMIS has publicly released its quarterly financial results and condition. For shareholders and analysts, the press release will contain the actual earnings, revenue, cash position, and any other operational metrics for the quarter; those figures are not detailed in the 8‑K itself. Investors should review the furnished press release on the company website or the Exhibit 99.1 filing to see the specific quarterly results and any management commentary.